Loss of IRF-4–binding protein leads to the spontaneous development of systemic autoimmunity
J. Clin. Invest. Jessica C. Fanzo, et al. 116:703 doi:10.1172/JCI24096 [
Go to this article.]

Figure 3Accumulation of effector/memory-like T cells and terminally differentiated B cells in aging
IBPtrap/trap mice. (
A) Increased effector/memory T cells in aging
IBPtrap/trap female mice. Cell suspensions from spleen (top panels), and lymph nodes (bottom panels) from older
IBP+/+ and
IBPtrap/trap mice were stained with antibodies against CD4, CD44, and CD62L to evaluate the presence of naive (CD44
loCD62L
hi) and effector/memory (CD44
hiCD62L
lo) T cells. Dot plots represent gated CD4
+ populations. Percentages of positive cells within each gate are shown. Results are representative of 5 different mice. (
B) Alterations of B cell populations in aging
IBPtrap/trap female mice. Single-cell suspensions from spleen (top panels) and lymph nodes (bottom panels) from aging
IBP+/+ and
IBPtrap/trap female mice were stained with antibodies against B220, IgM, and IgD. Cell staining was analyzed by FACS. Dot plots represent gated B220
+ populations. Percentages of positive cells within each gate are shown. (
C) Increased plasma cells in spleens of aging
IBPtrap/trap female mice. Single-cell suspensions from spleen (top panels) and bone marrow (bottom panels) from
IBP+/+ and older
IBPtrap/trap female mice were stained with antibodies against B220 and syndecan-1. Cell staining was analyzed by FACS. Percentages of syndecan-1–positive cells within each gate are shown. (
D) Syndecan-1 and PNA staining of spleens of aging
IBPtrap/trap female mice. Anti–syndecan-1 (blue) and anti-PNA (red) staining were performed on spleens from
IBP+/+ (left panel) and
IBPtrap/trap (right panel) mice. Light microscopy magnification, ×10. (
E) Accumulation of IgG1
+ cells in spleens of aging
IBPtrap/trap female mice. Anti-IgG1 (blue) staining was performed on spleens from
IBP+/+ (left panel) and
IBPtrap/trap (right panel) mice. Light microscopy magnification, ×10.